Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: A single institution experience from 1999 to 2010-Reference-Cited by-同舟云学术

Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: A single institution experience from 1999 to 2010

Published:2013-10 Issue:1 Volume:131 Page:163-168
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hou June Y.,Aparo Santiago,Ghalib Mohammad,Chaudhary Imran,Shah Umang,Swami Umang,Einstein Mark,Goldberg Gary L.,Mani Sridhar,Goel Sanjay

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference62 articles.

1. An overview of the optimal planning, design, and conduct of phase I studies of new therapeutics;LoRusso;Clin Cancer Res,2010

2. Ethics of phase 1 oncology studies: reexamining the arguments and data;Agrawal;JAMA,2003

3. Risks and benefits of phase 1 oncology trials, 1991 through 2002;Horstmann;N Engl J Med,2005

4. Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience;Arkenau;Br J Cancer,2008

5. Responses and toxic deaths in phase I clinical trials;Decoster;Ann Oncol,1990

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors;Investigational New Drugs;2024-08-03

2. Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials;JAMA Network Open;2024-07-11

3. Preoperative Hypoalbuminemia Is Associated with Increased Mortality in Patients Undergoing Surgery for Gynaecologic Malignancy – A Retrospective Cohort Study;Journal of Obstetrics and Gynaecology Canada;2023-06

4. Phase I trials and therapeutic intent in the age of precision oncology: What is a patient's chance of response?;European Journal of Cancer;2020-11

5. Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity;Gynecologic Oncology;2020-06